SCHEMBL6667573

SCHEMBL6667573

COc1ccc(-c2ccc3cc(OC)ccc3c2-c2cccc(O)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 11/20 0.52
HSD17B2 P37059 11/20 0.52
CYP1A2 P05177 6/20 0.52
CYP3A4 P08684 6/20 0.52
CYP2C9 P11712 6/20 0.52
CYP2C19 P33261 6/20 0.52
CYP2D6 P10635 5/20 0.52
CYP2B6 P20813 4/20 0.52
BACE1 P56817 1/20 0.47
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ESR1 P03372 2/20 0.43
ESR2 Q92731 2/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6088276 0.80 SMN1; SMN2 (0.49) HSD17B1HSD17B2CYP1A2CYP3A4CYP2C9
SCHEMBL6668074 0.80 MAOB (0.54) MAPK1NOD2
SCHEMBL225146 0.79 ESR1 (0.53) HSD17B1HSD17B2CYP1A2CYP3A4CYP2C9
SCHEMBL6086911 0.77 ESR2 (0.54) CYP3A4CYP2C9CYP2C19CYP2D6BACE1
SCHEMBL6671006 0.77 MTNR1A (0.39) BACE1CYP11B1CYP11B2
SCHEMBL6050101 0.76 CYP1A2 (0.49) HSD17B1HSD17B2CYP1A2CYP3A4CYP2C9
SCHEMBL1026075 0.75 HSD17B1 (0.68) HSD17B1HSD17B2CYP1A2CYP3A4CYP2C9
SCHEMBL14274032 0.73 ALOX5 (0.47) HSD17B1HSD17B2CYP1A2CYP3A4CYP2C9
SCHEMBL14274050 0.73 ALOX5 (0.40) HSD17B1HSD17B2CYP1A2CYP3A4CYP2C9
SCHEMBL7705320 0.73 ESR2 (0.53) CYP3A4CYP2C9CYP2C19CYP2D6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0838459-B1 Naphthyl compounds, compositions, and methods LILLY CO ELI (US) 2004-09-22 EP disclosed
US-5952350-A INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, AND CARDIOVASCULAR DISORDERS INCLUDING HYPERLIPIDEMIA, AND ESTROGEN DEPENDENT CANCER ELI LILLY AND COMPANY (US) 1999-09-14 US disclosed
EP-0838459-A1 Naphthyl compounds, compositions, and methods ELI LILLY AND COMPANY (US) 1998-04-29 EP disclosed